letrozole has been researched along with Muscle Weakness in 1 studies
Muscle Weakness: A vague complaint of debility, fatigue, or exhaustion attributable to weakness of various muscles. The weakness can be characterized as subacute or chronic, often progressive, and is a manifestation of many muscle and neuromuscular diseases. (From Wyngaarden et al., Cecil Textbook of Medicine, 19th ed, p2251)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wright, LE | 1 |
| Harhash, AA | 1 |
| Kozlow, WM | 1 |
| Waning, DL | 1 |
| Regan, JN | 1 |
| She, Y | 1 |
| John, SK | 1 |
| Murthy, S | 1 |
| Niewolna, M | 1 |
| Marks, AR | 1 |
| Mohammad, KS | 1 |
| Guise, TA | 1 |
1 other study available for letrozole and Muscle Weakness
| Article | Year |
|---|---|
Aromatase inhibitor-induced bone loss increases the progression of estrogen receptor-negative breast cancer in bone and exacerbates muscle weakness in vivo.
Topics: Animals; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Bone Density; Bone Density Conservat | 2017 |